Spina E - Search Results

1

Improved enantioselective assay for the determination of fluoxetine and norfluoxetine enantiomers in human plasma by liquid chromatography.

Gatti G, Bonomi I, Marchiselli R, Fattore C, Spina E, Scordo G, Pacifici R, Perucca E. Gatti G, et al. Among authors: spina e. J Chromatogr B Analyt Technol Biomed Life Sci. 2003 Feb 5;784(2):375-83. doi: 10.1016/s1570-0232(02)00820-6. J Chromatogr B Analyt Technol Biomed Life Sci. 2003. PMID: 12505785

2

Plasma concentrations of the enantiomers of fluoxetine and norfluoxetine: sources of variability and preliminary observations on relations with clinical response.

Jannuzzi G, Gatti G, Magni P, Spina E, Pacifici R, Zuccaro P, Torta R, Guarneri L, Perucca E. Jannuzzi G, et al. Among authors: spina e. Ther Drug Monit. 2002 Oct;24(5):616-27. doi: 10.1097/00007691-200210000-00006. Ther Drug Monit. 2002. PMID: 12352933

3

Inhibition of risperidone metabolism by fluoxetine in patients with schizophrenia: a clinically relevant pharmacokinetic drug interaction.

Spina E, Avenoso A, Scordo MG, Ancione M, Madia A, Gatti G, Perucca E. Spina E, et al. J Clin Psychopharmacol. 2002 Aug;22(4):419-23. doi: 10.1097/00004714-200208000-00014. J Clin Psychopharmacol. 2002. PMID: 12172343

4

Influence of CYP2C9, 2C19 and 2D6 genetic polymorphisms on the steady-state plasma concentrations of the enantiomers of fluoxetine and norfluoxetine.

Scordo MG, Spina E, Dahl ML, Gatti G, Perucca E. Scordo MG, et al. Among authors: spina e. Basic Clin Pharmacol Toxicol. 2005 Nov;97(5):296-301. doi: 10.1111/j.1742-7843.2005.pto_194.x. Basic Clin Pharmacol Toxicol. 2005. PMID: 16236141 Free article.

5

Issues in methodology and applications for therapeutic drug monitoring of fluoxetine and norfluoxetine enantiomers.

Zuccaro P, Pacifici R, Altieri I, Avenoso A, Pellegrini M, Spina E, Perucca E, Pichini S. Zuccaro P, et al. Among authors: spina e. Ther Drug Monit. 1998 Feb;20(1):20-4. doi: 10.1097/00007691-199802000-00004. Ther Drug Monit. 1998. PMID: 9485549

6

Clinical pharmacokinetics of fluvoxamine.

Perucca E, Gatti G, Spina E. Perucca E, et al. Among authors: spina e. Clin Pharmacokinet. 1994 Sep;27(3):175-90. doi: 10.2165/00003088-199427030-00002. Clin Pharmacokinet. 1994. PMID: 7988100 Review.

7

Determination of clozapine, desmethylclozapine and clozapine N-oxide in human plasma by reversed-phase high-performance liquid chromatography with ultraviolet detection.

Avenoso A, Facciolà G, Campo GM, Fazio A, Spina E. Avenoso A, et al. Among authors: spina e. J Chromatogr B Biomed Sci Appl. 1998 Sep 4;714(2):299-308. doi: 10.1016/s0378-4347(98)00202-3. J Chromatogr B Biomed Sci Appl. 1998. PMID: 9766870

8

Clinical significance of pharmacokinetic interactions between antiepileptic and psychotropic drugs.

Spina E, Perucca E. Spina E, et al. Epilepsia. 2002;43 Suppl 2:37-44. doi: 10.1046/j.1528-1157.2002.043s2037.x. Epilepsia. 2002. PMID: 11903482 Free article. Review.

9

Effect of fluoxetine on the plasma concentrations of clozapine and its major metabolites in patients with schizophrenia.

Spina E, Avenoso A, Facciolà G, Fabrazzo M, Monteleone P, Maj M, Perucca E, Caputi AP. Spina E, et al. Int Clin Psychopharmacol. 1998 May;13(3):141-5. doi: 10.1097/00004850-199805000-00009. Int Clin Psychopharmacol. 1998. PMID: 9690983

10

CYP2D6-related oxidation polymorphism in Italy.

Spina E, Campo GM, Avenoso A, Caputi AP, Zuccaro P, Pacifici R, Gatti G, Strada G, Bartoli A, Perucca E. Spina E, et al. Pharmacol Res. 1994 Apr;29(3):281-9. doi: 10.1016/1043-6618(94)80051-0. Pharmacol Res. 1994. PMID: 8058599

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

411 results

Search Page

Filters